Category Archives: Marketing & Sales
Schizophrenia – Pipeline Insight, 2026 DelveInsight’s latest report provides comprehensive insights about 55+ companies, such as Sunovion Pharmaceuticals, AbbVie, Karuna Therapeutics, Boehringer Ingelheim, Merck & Co., MapLight Therapeutics, Denovo Biopharma, Cyclerion Therapeutics, and others, developing several pipeline drugs in the … Continue reading
Autistic Disorder Pipeline Key Autistic Disorder companies include AbbVie, Yamo Pharmaceuticals, Stalicla SA, Vanda Pharmaceuticals, Paxmedica, SciSparc, Scioto Biosciences, Hoffmann-La Roche, ACADIA Pharmaceuticals Inc., Neurotech International, Neuren Pharmaceuticals, MapLight Therapeutics, Jazz Pharmaceuticals, Axial Therapeutics Inc., and several others. DelveInsight’s “Autistic … Continue reading
Multiple Sclerosis Pipeline Multiple Sclerosis companies include Novartis, Sanofi, Immunic, Biocad, Apimeds, Genentech (Roche), Merck, AB Science, Apurano Pharmaceuticals, Biogen, Tiziana Life Sciences, Worg Pharmaceuticals, Antisense Therapeutics, RemeGen, Atara Biotherapeutics, Contineum Therapeutics, Stem Cell Medicine Ltd., Ever Supreme Bio Technology … Continue reading
HER2-Negative Metastatic Breast Cancer Market Major companies actively participating in the HER2-Negative Metastatic Breast Cancer market include Genentech, Inc., AstraZeneca, Merck Sharp & Dohme LLC, Gilead Sciences, BeiGene, Eisai Inc., Novartis Pharmaceuticals, Adagene Inc., Jiangsu HengRui Medicine Co., Ltd., Pfizer, … Continue reading
Atopic Dermatitis Pipeline Atopic Dermatitis companies including Pfizer, Kymera Therapeutics, BenevolentAI, AstraZeneca, Qurient, Sterna Biologicals, Vanda Pharmaceuticals, and Arcutis Biotherapeutics, among others are actively developing treatment options for atopic dermatitis. The “Atopic Dermatitis Pipeline Insight, 2026” report by DelveInsight presents … Continue reading
Chronic Spontaneous Urticaria Pipeline Chronic Spontaneous Urticaria Companies include Novartis, Hangzhou Highlightll Pharmaceutical Co., Ltd, Celldex Therapeutics, Jemincare, Yuhan Corporation, United BioPharma, Septerna, Recludix Pharma, among others. DelveInsight’s report titled “Chronic Spontaneous Urticaria Pipeline Insight 2026” offers an extensive evaluation … Continue reading
A visually rich children’s story about persistence, problem-solving, and the courage to try again. Some stories entertain children for a moment. Others quietly stay with them, shaping how they think about challenges and possibilities. Farming in the River, a thoughtful … Continue reading
Deyanira Feliz: Leading Media Innovation for the Latino Community in the DMV
Washington, D.C. – Over the past five years, media entrepreneur Deyanira Feliz has built more than a magazine, she has created a movement of visibility, empowerment, and opportunity for entrepreneurs, creatives, and community leaders throughout the DMV region (Washington D.C., Maryland, … Continue reading
Independent fashion designers and small creative teams are embracing a new era where AI platforms are transforming how apparel is designed, visualized, and marketed online. Leading solutions like Style3D AI, ZMO AI, Runway, Pika Labs, Browzwear, TUKAcad, and Adobe Firefly … Continue reading
The Key Parkinson’s Disease Companies in the market include – FAScinate Therapeutics, Hoffmann-La Roche, Pharma Two B Ltd., Neuropore Therapies, Inc., Olatec Therapeutics, UCB Biopharma, Vaxxinity, Modag, Peptron, Kissei Pharmaceutical, Cerevel Therapeutics, and others. DelveInsight’s “Parkinson’s Disease Market Insights, … Continue reading
